NAFLD is closely linked with peripheral insulin resistance and hepatic insulin resistance (28–30), a condition where insulin fails to suppress hepatic glucose production (HPG, which accounts for 90% of endogenous glucose production) but promotes lipid synthesis leading to hyperglycemia, hypertriglyceridemia and hepatic steatosis (31). This evidence concerns the gene INS and fatty liver disease.